NASDAQ:INSM News 14 August 2025

Insmed Incorporated (NASDAQ: INSM) Stock Week Ahead: Nasdaq-100 Addition Meets Brensocatib Setback—News, Forecasts, and What to Watch (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Insmed Incorporated (NASDAQ: INSM) is heading into a pivotal (and holiday-shortened) trading week with two narratives pulling on sentiment at the same time: That push-pull dynamic is likely to define the week-ahead setup for

21 December 2025

NASDAQ:INSM

Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

December 20, 2025 — Insmed Incorporated (NASDAQ: INSM) is ending the week in “re-pricing mode” after a mid-stage clinical setback jolted investor expectations, sparked sharp volatility, and triggered a round of analyst price-target revisions. By Friday’s close (the last U.S.

20 December 2025

Insmed (INSM) Stock After Hours on Dec. 19, 2025: Friday Rebound Holds, Analyst Targets Reset, and What to Watch Before the Next Market Open

Insmed Incorporated (NASDAQ: INSM) closed out a turbulent week with a sharp rebound on Friday, Dec. 19, 2025, and the move largely held after the bell—a sign that investors may be trying to stabilize expectations after the company’s latest clinical

20 December 2025

After Hours Trading · Analyst Ratings · Investing · Market Analysis · NASDAQ:INSM · Stock Market

Insmed Stock (INSM) Rebounds on Dec. 19, 2025 After BiRCh Trial Miss: Latest News, Analyst Forecasts, and What Comes Next

December 19, 2025 — Insmed Incorporated (NASDAQ: INSM) is back in focus today after a sharp, news-driven selloff on Thursday and a noticeable bounce on Friday. As of 15:46 UTC on Dec. 19, INSM shares were trading around $174.90, up

19 December 2025

Analyst Forecasts · Biotech News · Financial Updates · Investment Strategies · NASDAQ:INSM · Stock Market

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

December 18, 2025 — Insmed Incorporated (NASDAQ: INSM) shares dropped sharply Thursday after the company disclosed a Phase 2b setback for brensocatib in a chronic sinus condition and said it is discontinuing development in that indication, even as it simultaneously

18 December 2025

Biotechnology · Earnings Reports · Investment Analysis · NASDAQ:INSM · Pharma News · Stock Market

Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Official press releases, government health agency updates, and reputable media coverage were used in

14 August 2025

Biotech · Global News · Health · Medicine · NASDAQ:INSM · NASDAQ:RGEN · NYSE:NVS · Vaccines

Tech World Rocked by 8 Non‑AI Surprises This Week

Apple is developing a home companion robot—a 7-inch iPad-like display on a movable arm—targeting a 2027 launch, internally dubbed the “Pixar Lamp,” with a more lifelike, conversational Siri. Pebble Time 2 features a 1.5-inch color e-paper display, heart-rate sensor, and